Therapeutic drug monitoring of mycophenolic acid in patients with psoriasis

European Journal of Dermatology

Volumn 20, Issue 3, 2010, Pages 321-322

  Daudén, Esteban ^a   Pedraz, Javier ^b   Álvarez Ruiz, Sara ^a   García RíO, Irene ^a   Sánchez Peinado, Carmen ^c   Oñate, María Jesús ^d   García Diez, Amaro ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^d Centro de Especialidades de Fuencarral   (Spain)

Author keywords

Mycophenolate mofetil; Mycophenolic acid; Psoriasis

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG MONITORING; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; PSORIASIS VULGARIS; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG MONITORING; ENZYME INHIBITORS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PSORIASIS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77952853012     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2010.0899     Document Type: Article

References (6)

1. Orvis AK, Wesson SK, Breza Jr TS, et al. Mycophenolate mofetil in dermatology. J Am Acad Dermatol 2009; 60: 183-199
2. Dauden E, Sanchez-Peinado C, Ruiz-Genao D, et al. Plasma trough levels of mycophenolic acid do not correlate with efficacy and safety of mycophenolate mophetil in psoriasis. Br J Dermatol 2004; 150: 132-135
3. Filler G, Mai I. Limited sampling strategy for mycophenolic area under the curve. Ther Drug Monit 2000; 22: 169-173
4. Pawinski T, Hale M, Korecka M, Fitzsimmons WE, Shaw LM. Limited sampling strategy for the estimation of mycophenolic acid area under the curve in adult renal transplant patients treated with concomitant tacrolimus. Clin Chem 2002; 48: 1497-1504
5. Bullingham R, Monroe S, Nicholls A, et al. Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjets after single-dose oral and intravenous administration. J Clin Pharmacol 1996; 36: 315-324
6. Ensom MH, Partovi N, Decarie D, Dumont RJ, Fradet G, Levy RD. Pharmacokinetics and protein binding of mycophenolic acid in stable lung transplant recipients. Ther Drug Monitor 2002; 24: 310-314